Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Arhgap17 | Mouse | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ARHGAP17 mRNA | CTD | PMID:22206623 | Arhgap17 | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGAP17 mRNA | CTD | PMID:22206623 | Arhgap17 | Mouse | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGAP17 mRNA | CTD | PMID:17942748 | Arhgap17 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGAP17 mRNA | CTD | PMID:17942748 | Arhgap17 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARHGAP17 mRNA | CTD | PMID:34747641 | Arhgap17 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARHGAP17 mRNA | CTD | PMID:21570461 | Arhgap17 | Mouse | 2,6-dinitrotoluene | affects expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of ARHGAP17 mRNA | CTD | PMID:21346803 | Arhgap17 | Mouse | 2-hydroxypropanoic acid | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of ARHGAP17 mRNA | CTD | PMID:30851411 | Arhgap17 | Mouse | 2-methylcholine | affects expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of ARHGAP17 mRNA | CTD | PMID:21179406 | Arhgap17 | Mouse | 2-palmitoylglycerol | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of ARHGAP17 mRNA | CTD | PMID:37199045 | Arhgap17 | Mouse | 4,4'-sulfonyldiphenol | decreases methylation | ISO | ARHGAP17 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of ARHGAP17 gene | CTD | PMID:31601247 | Arhgap17 | Mouse | 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Oxazolone results in decreased expression of ARHGAP17 mRNA | CTD | PMID:17374397 | Arhgap17 | Mouse | 6-propyl-2-thiouracil | decreases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ARHGAP17 mRNA | CTD | PMID:24780913 | Arhgap17 | Mouse | acetamide | increases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of ARHGAP17 mRNA | CTD | PMID:31881176 | Arhgap17 | Mouse | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of ARHGAP17 mRNA | CTD | PMID:19770486 | Arhgap17 | Mouse | ammonium chloride | affects expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of ARHGAP17 mRNA | CTD | PMID:16483693 | Arhgap17 | Mouse | antirheumatic drug | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of ARHGAP17 mRNA | CTD | PMID:24449571 | Arhgap17 | Mouse | arsenite(3-) | multiple interactions | ISO | ARHGAP17 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to ARHGAP17 mRNA] | CTD | PMID:32406909 | Arhgap17 | Mouse | benzo[a]pyrene | decreases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Benzo(a)pyrene results in decreased expression of ARHGAP17 mRNA | CTD | PMID:21839799 | Arhgap17 | Mouse | benzo[a]pyrene | increases methylation | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ARHGAP17 promoter | CTD | PMID:27901495 | Arhgap17 | Mouse | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ARHGAP17 mRNA | CTD | PMID:25908611 | Arhgap17 | Mouse | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | Arhgap17 | Mouse | benzo[b]fluoranthene | decreases expression | EXP | | 6480464 | benzo(b)fluoranthene results in decreased expression of ARHGAP17 mRNA | CTD | PMID:26377693 | Arhgap17 | Mouse | bisphenol A | increases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ARHGAP17 mRNA | CTD | PMID:25181051 | Arhgap17 | Mouse | bisphenol A | affects expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | bisphenol A affects the expression of ARHGAP17 mRNA | CTD | PMID:30903817 | Arhgap17 | Mouse | bisphenol F | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of ARHGAP17 protein | CTD | PMID:34186270 | Arhgap17 | Mouse | buta-1,3-diene | decreases expression | EXP | | 6480464 | 1 and 3-butadiene results in decreased expression of ARHGAP17 mRNA | CTD | PMID:29038090 | Arhgap17 | Mouse | cadmium atom | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Cadmium results in increased expression of ARHGAP17 mRNA | CTD | PMID:24376830 | Arhgap17 | Mouse | cadmium dichloride | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of ARHGAP17 mRNA | CTD | PMID:38382870 | Arhgap17 | Mouse | cadmium dichloride | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of ARHGAP17 mRNA | CTD | PMID:38568856 | Arhgap17 | Mouse | caffeine | affects phosphorylation | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of ARHGAP17 protein | CTD | PMID:35688186 | Arhgap17 | Mouse | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes and Carbon results in decreased expression of ARHGAP17 mRNA | CTD | PMID:25554681 | Arhgap17 | Mouse | CGP 52608 | multiple interactions | ISO | ARHGAP17 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ARHGAP17 gene] | CTD | PMID:28238834 | Arhgap17 | Mouse | cisplatin | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ARHGAP17 mRNA | CTD | PMID:27594783 | Arhgap17 | Mouse | clothianidin | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | clothianidin results in increased expression of ARHGAP17 mRNA | CTD | PMID:31626844 | Arhgap17 | Mouse | Cuprizon | increases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of ARHGAP17 mRNA | CTD | PMID:26577399 | Arhgap17 | Mouse | cycloastragenol | multiple interactions | ISO | Arhgap17 (Rattus norvegicus) | 267358468 | cycloastragenol inhibits the reaction [acute myocardial infarction decreases expression of Arhgap17 protein in myocardium] | RGD | | Arhgap17 | Mouse | dibenzo[a,l]pyrene | increases expression | EXP | | 6480464 | dibenzo(a and l)pyrene results in increased expression of ARHGAP17 mRNA | CTD | PMID:25908611 | Arhgap17 | Mouse | Dibutyl phosphate | affects expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of ARHGAP17 mRNA | CTD | PMID:37042841 | Arhgap17 | Mouse | dicrotophos | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of ARHGAP17 mRNA | CTD | PMID:28302478 | Arhgap17 | Mouse | doxorubicin | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ARHGAP17 mRNA | CTD | PMID:29803840 | Arhgap17 | Mouse | epoxiconazole | decreases expression | EXP | | 6480464 | epoxiconazole results in decreased expression of ARHGAP17 mRNA | CTD | PMID:35436446 | Arhgap17 | Mouse | eugenol | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Eugenol results in decreased expression of ARHGAP17 mRNA | CTD | PMID:17374397 | Arhgap17 | Mouse | fenthion | decreases expression | EXP | | 6480464 | Fenthion results in decreased expression of ARHGAP17 mRNA | CTD | PMID:34813904 | Arhgap17 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGAP17 mRNA | CTD | PMID:22206623 | Arhgap17 | Mouse | FR900359 | increases phosphorylation | ISO | ARHGAP17 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of ARHGAP17 protein | CTD | PMID:37730182 | Arhgap17 | Mouse | gentamycin | increases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of ARHGAP17 mRNA | CTD | PMID:22061828 | Arhgap17 | Mouse | hydrogen peroxide | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5 more ... | CTD | PMID:31494107 | Arhgap17 | Mouse | ivermectin | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ARHGAP17 protein | CTD | PMID:32959892 | Arhgap17 | Mouse | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of ARHGAP17 mRNA | CTD | PMID:21829687 | Arhgap17 | Mouse | methyl methanesulfonate | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of ARHGAP17 mRNA | CTD | PMID:23649840 | Arhgap17 | Mouse | motexafin gadolinium | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | motexafin gadolinium results in decreased expression of ARHGAP17 mRNA | CTD | PMID:16357179 | Arhgap17 | Mouse | motexafin gadolinium | multiple interactions | ISO | ARHGAP17 (Homo sapiens) | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ARHGAP17 mRNA | CTD | PMID:16357179 | Arhgap17 | Mouse | nickel sulfate | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of ARHGAP17 mRNA | CTD | PMID:17374397 | Arhgap17 | Mouse | oxaliplatin | multiple interactions | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ARHGAP17 mRNA | CTD | PMID:25729387 | Arhgap17 | Mouse | paracetamol | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ARHGAP17 mRNA | CTD | PMID:26690555 | Arhgap17 | Mouse | pentane-2,3-dione | increases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | 2 and 3-pentanedione results in increased expression of ARHGAP17 mRNA | CTD | PMID:25710175 | Arhgap17 | Mouse | phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ARHGAP17 mRNA] | CTD | PMID:19482888 | Arhgap17 | Mouse | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of ARHGAP17 mRNA | CTD | PMID:19482888 | Arhgap17 | Mouse | potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of ARHGAP17 mRNA | CTD | PMID:23608068 | Arhgap17 | Mouse | quercetin | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Quercetin results in increased expression of ARHGAP17 mRNA | CTD | PMID:21632981 | Arhgap17 | Mouse | rac-lactic acid | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of ARHGAP17 mRNA | CTD | PMID:30851411 | Arhgap17 | Mouse | Soman | increases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Soman results in increased expression of ARHGAP17 mRNA | CTD | PMID:19281266 | Arhgap17 | Mouse | sunitinib | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of ARHGAP17 mRNA | CTD | PMID:31533062 | Arhgap17 | Mouse | thapsigargin | decreases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Thapsigargin results in decreased expression of ARHGAP17 protein | CTD | PMID:35544339 | Arhgap17 | Mouse | thioacetamide | increases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ARHGAP17 mRNA | CTD | PMID:34492290 | Arhgap17 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of ARHGAP17 promoter alternative form | CTD | PMID:35295148 | Arhgap17 | Mouse | topotecan | multiple interactions | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ARHGAP17 mRNA | CTD | PMID:25729387 | Arhgap17 | Mouse | topotecan | decreases expression | ISO | Arhgap17 (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of ARHGAP17 mRNA | CTD | PMID:25729387 | Arhgap17 | Mouse | triphenyl phosphate | affects expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ARHGAP17 mRNA | CTD | PMID:37042841 | Arhgap17 | Mouse | triptonide | affects expression | EXP | | 6480464 | triptonide affects the expression of ARHGAP17 mRNA | CTD | PMID:33045310 | Arhgap17 | Mouse | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of ARHGAP17 mRNA | CTD | PMID:30912803 | Arhgap17 | Mouse | urethane | increases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Urethane results in increased expression of ARHGAP17 mRNA | CTD | PMID:28818685 | Arhgap17 | Mouse | zinc acetate | multiple interactions | ISO | ARHGAP17 (Homo sapiens) | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ARHGAP17 mRNA | CTD | PMID:16357179 | Arhgap17 | Mouse | zinc acetate | decreases expression | ISO | ARHGAP17 (Homo sapiens) | 6480464 | Zinc Acetate results in decreased expression of ARHGAP17 mRNA | CTD | PMID:16357179 | |